Cargando…

Relationship Between Standardized Measures of Chronic Kidney Disease-associated Pruritus Intensity and Health-related Quality of Life Measured with the EQ-5D Questionnaire: A Mapping Study

Chronic kidney disease-associated pruritus is linked with decreased health-related quality of life assessed using disease-specific instruments. The extent to which worsening pruritus reduces generic quality of life assessed using the EQ-5D instrument is unknown. Prevalent kidney failure patients rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	HERNANDEZ ALAVA, Monica, SASSO, Alessandro, HNYNN SI, Pann Ei, GITTUS, Matthew, POWELL, Richard, DUNN, Louese, THOKALA, Praveen, FOTHERINGHAM, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522326/ https://www.ncbi.nlm.nih.gov/pubmed/37731210 http://dx.doi.org/10.2340/actadv.v103.11604

Ejemplares similares

Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis
por: Thokala, Praveen, et al.
Publicado: (2023)

The trajectory of a range of commonly captured symptoms with standard care in people with kidney failure receiving haemodialysis: consideration for clinical trial design
por: Hnynn Si, Pann Ei, et al.
Publicado: (2023)

Symptom burden according to dialysis day of the week in three times a week haemodialysis patients
por: Hnynn Si, Pann Ei, et al.
Publicado: (2022)

The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review
por: Poku, Edith, et al.
Publicado: (2021)

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data
por: Hernández‐Alava, Mónica, et al.
Publicado: (2022)

Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
por: Pennington, Becky M., et al.
Publicado: (2020)

Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
por: Gray, Laura A., et al.
Publicado: (2021)

Mapping EQ-5D-3L from the Knee Injury and Osteoarthritis Outcome Score (KOOS)
por: Kiadaliri, Ali, et al.
Publicado: (2019)

Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
por: Gray, Laura A., et al.
Publicado: (2022)

Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma
por: Gray, Laura A., et al.
Publicado: (2018)

Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review
por: Gittus, Matthew, et al.
Publicado: (2023)

Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study
por: Fotheringham, James, et al.
Publicado: (2022)

Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study
por: Hernández Alava, Mónica, et al.
Publicado: (2022)

Mapping health outcome measures from a stroke registry to EQ-5D weights
por: Ghatnekar, Ola, et al.
Publicado: (2013)

Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping
por: Gray, Laura A., et al.
Publicado: (2018)

Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()
por: Hernández-Alava, Mónica, et al.
Publicado: (2017)

The effectiveness and value of belimumab and voclosporin for lupus nephritis: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council
por: Tice, Jeffrey A, et al.
Publicado: (2021)

Modelling the relationship between the WOMAC osteoarthritis index and EQ-5D
por: Wailoo, Allan, et al.
Publicado: (2014)

Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database
por: Dakin, Helen
Publicado: (2013)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
por: Banypersad, Sanjay M, et al.
Publicado: (2013)

Mapping health assessment questionnaire disability index onto EQ-5D-5L in China
por: Wan, Chuchuan, et al.
Publicado: (2023)

Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease
por: Li, Chaofan, et al.
Publicado: (2023)

Validity and Reliability of Persian Version of 12-Item Pruritus Severity Score Questionnaire in Patients with Chronic Liver Disease and Pruritus
por: Esmaeili, Ayda, et al.
Publicado: (2020)

The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis
por: Hernández Alava, Mónica, et al.
Publicado: (2013)

Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL
por: Hatswell, Anthony James, et al.
Publicado: (2016)

Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
por: Aghdaee, Mona, et al.
Publicado: (2022)

Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches
por: Acaster, Sarah, et al.
Publicado: (2015)

Enabling QALY estimation in mental health trials and care settings: mapping from the PHQ-9 and GAD-7 to the ReQoL-UI or EQ-5D-5L using mixture models
por: Franklin, Matthew, et al.
Publicado: (2023)

Measurement properties of the EQ-5D-Y administered through a smartphone app in children with asthma: a longitudinal questionnaire study
por: Mayoral, Karina, et al.
Publicado: (2022)

Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease
por: Goldsmith, Kimberley A, et al.
Publicado: (2010)

Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities
por: Gu, Ning Yan, et al.
Publicado: (2011)

Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures
por: Lee, Min-Sang, et al.
Publicado: (2020)

Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement
por: Dakin, Helen, et al.
Publicado: (2018)

Use of Bayesian Multivariate Meta-Analysis to Estimate the HAQ for Mapping Onto the EQ-5D Questionnaire in Rheumatoid Arthritis
por: Bujkiewicz, Sylwia, et al.
Publicado: (2014)

Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure
por: Kularatna, Sanjeewa, et al.
Publicado: (2020)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Danish population health measured by the EQ-5D-5L
por: Jensen, Morten B., et al.
Publicado: (2021)

Translation and Validation of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR)
por: Mendes, Guilherme Falcão, et al.
Publicado: (2020)

Pruritus
Publicado: (1876)

Cannot write session to /tmp/vufind_sessions/sess_f4mnmem4ds8alb3cfep2cpvlng